Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Traveller's diarrhoea vaccine - Scandinavian Biopharma

Next Previous
X
Search
Drug Profile

Traveller's diarrhoea vaccine - Scandinavian Biopharma

Alternative Names: Enterotoxigenic Escherichia coli vaccine - Scandinavian Biopharma; ETEC vaccine - Scandinavian Biopharma; Etvax

Latest Information Update: 07 Mar 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Scandinavian Biopharma
  • Developer PATH; Scandinavian Biopharma
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Traveller's diarrhoea

Most Recent Events

  • 12 Feb 2024 Scandinavian Biopharma initiates a clinical trials in Traveller's diarrhoea (Prevention) in USA (PO) (NCT06290089)
  • 20 Oct 2022 Scandinavian Biopharma AB completes a phase II trial in Traveller's diarrhoea (Prevention) in Sweden (PO) (EUdraCT2021-001541-13) (NCT05178134)
  • 28 Jul 2022 No recent reports of development identified for phase-I development in Traveller's-diarrhoea(In children, In infants, Prevention, In adults) in Zambia (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top